Laboratory Workup for Gallstones
Begin with liver function tests (LFTs) including bilirubin, AST, ALT, and alkaline phosphatase, combined with abdominal ultrasound as your initial diagnostic approach 1.
Initial Laboratory Panel
When evaluating suspected gallstone disease, obtain the following blood tests at admission:
- Liver chemistries: Bilirubin, AST, ALT, and alkaline phosphatase 1
- Serum amylase or lipase (to assess for pancreatitis) 1
- Triglyceride level 1
- Calcium level 1
Rationale for This Approach
The combination of LFTs and imaging helps differentiate between simple cholelithiasis and complications like choledocholithiasis (common bile duct stones). Elevated bilirubin >22.23 μmol/L has 84% sensitivity and 91% specificity for detecting bile duct stones 2. Alkaline phosphatase elevation occurs in approximately 41% of gallstone patients 3.
Risk Stratification Based on Laboratory Results
High-Risk Features Suggesting Bile Duct Stones:
- Bilirubin elevation (particularly >22.23 μmol/L)
- Elevated alkaline phosphatase
- Elevated transaminases (AST/ALT)
- Dilated common bile duct on ultrasound (>6-10 mm)
When these findings are present together, they create a 4-fold increased risk for choledocholithiasis 4.
Pancreatitis Screening:
If amylase or lipase is elevated ≥3 times the upper limit of normal, this indicates acute pancreatitis 5. In this context:
- Measure triglycerides: levels >1000 mg/dl (11.3 mmol/L) indicate hypertriglyceridemia as the etiology 5
- C-reactive protein ≥150 mg/L at 48-72 hours predicts severe pancreatitis 5, 1
Common Pitfalls to Avoid
Normal LFTs do not exclude choledocholithiasis: Up to 20% of patients with bile duct stones have normal liver enzymes 2. If clinical suspicion remains high despite normal labs, proceed with advanced imaging (MRCP or EUS).
Timing matters for enzyme levels: Amylase peaks at 48 hours and normalizes by 3-7 days, while lipase remains elevated longer (8-14 days) 5. A normal amylase doesn't exclude recent pancreatitis if measured late.
Don't rely solely on ultrasound for bile duct stones: Transabdominal ultrasound has only 22.5-75% sensitivity for detecting choledocholithiasis due to overlying bowel gas 4. The negative predictive value is 95-96% only when the common bile duct appears normal in caliber.
Algorithm for Further Testing
If LFTs are abnormal OR clinical suspicion is high:
- Proceed to MRCP or endoscopic ultrasound (EUS) rather than diagnostic ERCP 5, 2
- MRCP has 97.98% sensitivity and 84.4% specificity for choledocholithiasis 5
- EUS is equally accurate and preferred when MRCP is contraindicated or unavailable 2
If gallstone pancreatitis with cholangitis or persistent bile duct obstruction:
- Urgent ERCP within 24-72 hours is indicated 1
- This is both diagnostic and therapeutic
Additional Considerations
For patients with unexplained pancreatitis and no obvious gallstones on initial ultrasound, measure fasting triglycerides after recovery when normal intake resumes 1. In patients over 40 years with unexplained pancreatitis, advanced imaging (CT or EUS) should evaluate for underlying pancreatic malignancy 1.
Complete blood count may show elevated hematocrit >44%, which independently predicts pancreatic necrosis in acute pancreatitis 5. Urea >20 mg/dl predicts mortality 5.